全文获取类型
收费全文 | 49522篇 |
免费 | 6141篇 |
国内免费 | 292篇 |
专业分类
耳鼻咽喉 | 699篇 |
儿科学 | 1587篇 |
妇产科学 | 1402篇 |
基础医学 | 5386篇 |
口腔科学 | 961篇 |
临床医学 | 5301篇 |
内科学 | 10956篇 |
皮肤病学 | 1252篇 |
神经病学 | 3835篇 |
特种医学 | 1719篇 |
外科学 | 8499篇 |
综合类 | 1057篇 |
现状与发展 | 1篇 |
一般理论 | 16篇 |
预防医学 | 3136篇 |
眼科学 | 2123篇 |
药学 | 3321篇 |
1篇 | |
中国医学 | 264篇 |
肿瘤学 | 4439篇 |
出版年
2023年 | 935篇 |
2022年 | 528篇 |
2021年 | 1389篇 |
2020年 | 1055篇 |
2019年 | 1213篇 |
2018年 | 1860篇 |
2017年 | 1600篇 |
2016年 | 1666篇 |
2015年 | 1809篇 |
2014年 | 2375篇 |
2013年 | 2571篇 |
2012年 | 3248篇 |
2011年 | 3326篇 |
2010年 | 2283篇 |
2009年 | 2162篇 |
2008年 | 2782篇 |
2007年 | 2534篇 |
2006年 | 2426篇 |
2005年 | 2265篇 |
2004年 | 2164篇 |
2003年 | 1874篇 |
2002年 | 1747篇 |
2001年 | 1474篇 |
2000年 | 1309篇 |
1999年 | 1153篇 |
1998年 | 453篇 |
1997年 | 390篇 |
1996年 | 320篇 |
1995年 | 319篇 |
1994年 | 273篇 |
1993年 | 228篇 |
1992年 | 656篇 |
1991年 | 598篇 |
1990年 | 540篇 |
1989年 | 492篇 |
1988年 | 449篇 |
1987年 | 388篇 |
1986年 | 378篇 |
1985年 | 386篇 |
1984年 | 265篇 |
1983年 | 250篇 |
1982年 | 179篇 |
1981年 | 153篇 |
1980年 | 138篇 |
1979年 | 199篇 |
1978年 | 121篇 |
1977年 | 132篇 |
1976年 | 89篇 |
1974年 | 99篇 |
1973年 | 96篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
1.
Raymond J. Chan RN PhD Vivienne E. Milch MBBS MHPol Fiona Crawford-Williams PhD Oluwaseyifunmi Andi Agbejule BRadTherapy Ria Joseph MNutrDiet Jolyn Johal BND Narayanee Dick BSc Matthew P. Wallen PhD Julie Ratcliffe PhD Anupriya Agarwal MBBS Larissa Nekhlyudov MD Matthew Tieu PhD Manaf Al-Momani BPharm Scott Turnbull PhD Rahul Sathiaraj MPH Dorothy Keefe MBBS MD Nicolas H. Hart PhD 《CA: a cancer journal for clinicians》2023,73(6):565-589
Patient navigation is a strategy for overcoming barriers to reduce disparities and to improve access and outcomes. The aim of this umbrella review was to identify, critically appraise, synthesize, and present the best available evidence to inform policy and planning regarding patient navigation across the cancer continuum. Systematic reviews examining navigation in cancer care were identified in the Cochrane Central Register of Controlled Trials (CENTRAL), PubMed, Embase, Cumulative Index of Nursing and Allied Health (CINAHL), Epistemonikos, and Prospective Register of Systematic Reviews (PROSPERO) databases and in the gray literature from January 1, 2012, to April 19, 2022. Data were screened, extracted, and appraised independently by two authors. The JBI Critical Appraisal Checklist for Systematic Review and Research Syntheses was used for quality appraisal. Emerging literature up to May 25, 2022, was also explored to capture primary research published beyond the coverage of included systematic reviews. Of the 2062 unique records identified, 61 systematic reviews were included. Fifty-four reviews were quantitative or mixed-methods reviews, reporting on the effectiveness of cancer patient navigation, including 12 reviews reporting costs or cost-effectiveness outcomes. Seven qualitative reviews explored navigation needs, barriers, and experiences. In addition, 53 primary studies published since 2021 were included. Patient navigation is effective in improving participation in cancer screening and reducing the time from screening to diagnosis and from diagnosis to treatment initiation. Emerging evidence suggests that patient navigation improves quality of life and patient satisfaction with care in the survivorship phase and reduces hospital readmission in the active treatment and survivorship care phases. Palliative care data were extremely limited. Economic evaluations from the United States suggest the potential cost-effectiveness of navigation in screening programs. 相似文献
2.
3.
4.
Danielle E Whittier Elizabeth J Samelson Marian T Hannan Lauren A Burt David A Hanley Emmanuel Biver Pawel Szulc Elisabeth Sornay-Rendu Blandine Merle Roland Chapurlat Eric Lespessailles Andy Kin On Wong David Goltzman Sundeep Khosla Serge Ferrari Mary L Bouxsein Douglas P Kiel Steven K Boyd 《Journal of bone and mineral research》2022,37(3):428-439
Prevalence of osteoporosis is more than 50% in older adults, yet current clinical methods for diagnosis that rely on areal bone mineral density (aBMD) fail to detect most individuals who have a fragility fracture. Bone fragility can manifest in different forms, and a “one-size-fits-all” approach to diagnosis and management of osteoporosis may not be suitable. High-resolution peripheral quantitative computed tomography (HR-pQCT) provides additive information by capturing information about volumetric density and microarchitecture, but interpretation is challenging because of the complex interactions between the numerous properties measured. In this study, we propose that there are common combinations of bone properties, referred to as phenotypes, that are predisposed to different levels of fracture risk. Using HR-pQCT data from a multinational cohort (n = 5873, 71% female) between 40 and 96 years of age, we employed fuzzy c-means clustering, an unsupervised machine-learning method, to identify phenotypes of bone microarchitecture. Three clusters were identified, and using partial correlation analysis of HR-pQCT parameters, we characterized the clusters as low density, low volume, and healthy bone phenotypes. Most males were associated with the healthy bone phenotype, whereas females were more often associated with the low volume or low density bone phenotypes. Each phenotype had a significantly different cumulative hazard of major osteoporotic fracture (MOF) and of any incident osteoporotic fracture (p < 0.05). After adjustment for covariates (cohort, sex, and age), the low density followed by the low volume phenotype had the highest association with MOF (hazard ratio = 2.96 and 2.35, respectively), and significant associations were maintained when additionally adjusted for femoral neck aBMD (hazard ratio = 1.69 and 1.90, respectively). Further, within each phenotype, different imaging biomarkers of fracture were identified. These findings suggest that osteoporotic fracture risk is associated with bone phenotypes that capture key features of bone deterioration that are not distinguishable by aBMD. © 2021 American Society for Bone and Mineral Research (ASBMR). 相似文献
5.
Xin Yi Wong Andrew Qi Jun Lim Qianyu Shen John Whay Kuang Chia Min Hoe Chew Wah Siew Tan 《Current medical research and opinion》2020,36(10):1677-1686
Abstract
Objective
Ras wild-type metastatic colorectal cancers (mCRC) may be treated with anti-vascular endothelial growth factor (VEGF) or anti-epidermal growth factor receptor (EGFR) agents. We aim to estimate patients’ preferences for mCRC treatment and relative importance of cost, efficacy improvement, avoidance of side effects and therapy convenience, and relative uptake between profiles that resemble Bevacizumab (anti-VEGF) and Cetuximab (anti-EGFR), two commonly prescribed mCRC targeted therapies. 相似文献6.
7.
8.
Nurse perceptions of the Nursing Delirium Screening Scale in two palliative care inpatient units: a focus group study 下载免费PDF全文
9.
10.